CAS 1039726-31-2

D-Tyrosinamide, 4-chloro-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-phenylalanyl-D-cysteinyl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide

Description:

D-Tyrosinamide, 4-chloro-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-phenylalanyl-D-cysteinyl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide, is a complex synthetic compound characterized by its intricate structure, which includes multiple amino acid residues and a cyclic disulfide linkage. This compound features a tetraazacyclododecane core, which contributes to its potential as a chelating agent or in drug delivery systems. The presence of various functional groups, such as carboxymethyl and amide groups, suggests that it may exhibit significant solubility in polar solvents and could participate in various biochemical interactions. Its chlorinated and cyclic disulfide components may enhance its stability and reactivity, making it of interest in medicinal chemistry and biochemistry. Overall, this compound's unique structural features may confer specific biological activities, warranting further investigation for potential therapeutic applications.

Formula: C₇₄H₉₈ClN₁₉O₂₁S₂

Synonyms:

• D-Tyrosinamide, 4-chloro-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-phenylalanyl-D-cysteinyl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide
• DOTA satoreotide/Satoreotide tetraxetan

DOTA-JR11

CAS: 1039726-31-2

DOTA-JR11 is a somatostatin receptor 2 (SSTR2) antagonist that can be radiolabeled with 68Ga.

Formula: C₇₄H₉₈ClN₁₉O₂₁S₂

Color and Shape: Solid

Molecular weight: 1689.27

Ref: TM-T80157